Home › Prostate Cancer › Florida › Hialeah
Prostate Cancer clinical trials in Hialeah, FL
5 studies for Prostate Cancer are looking for participants at sites in and around Hialeah (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
RecruitingPhase 3
- Research Site, Hialeah
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
RecruitingPhase 2
- Bioresearch Partner - Hialeah, Hialeah
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer
RecruitingHealthy volunteers welcome
- Urology Specialist Group, Hialeah
MRI/Ultrasound Fusion Guided Prostate Cryotherapy
RecruitingObservational study
- Urological Research Network, Miami Lakes · 4 mi away
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
RecruitingObservational study
- Urological Research Network, Miami Lakes · 4 mi away
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA61 studies
- St. Louis, MO47 studies
- Chicago, IL45 studies
- San Francisco, CA45 studies
- Philadelphia, PA44 studies
- Seattle, WA44 studies
- Nashville, TN43 studies
- Baltimore, MD42 studies
- Washington, DC38 studies
Other studies in Hialeah
- Obesity13 studies
- Schizophrenia13 studies
- Heart Failure12 studies
- Overweight10 studies
- Type 2 Diabetes9 studies
- Steatotic Liver Disease9 studies
- Major Depressive Disorder8 studies
- Atherosclerosis8 studies
- COPD8 studies
- Post-COVID Conditions (Long COVID)6 studies
- Cancer (all types)6 studies
- Cardiovascular Disease6 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.